Federal Register Notice: FDA is withdrawing approval of 13 NDAs and 7 ANDAs for products containing phenylpropanolamine. The products are no longer considered safe due to the association of phenylpropanolamine use with increased risk of hemorrhagic stroke. The holders of these NDAs and ANDAs have waived their opportunity for a hearing. To view this notice, click here.
